Page last updated: 2024-10-31

methylphenidate and Hallervorden-Spatz Disease

methylphenidate has been researched along with Hallervorden-Spatz Disease in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwon, KY1
Lee, HM1
Kim, M1
Kang, SH1
Koh, SB1

Other Studies

1 other study available for methylphenidate and Hallervorden-Spatz Disease

ArticleYear
Long-lasting isolated freezing of gait with good response to methylphenidate: A patient with pantothenate kinase-associated neurodegeneration.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:6

    Topics: Dopamine Uptake Inhibitors; Gait; Gait Disorders, Neurologic; Humans; Male; Methylphenidate; Middle

2015